Skip to content
Digene Corporation logo — Innovative, reliable gene-based diagnostic solutions targeti...

Digene Corporation

Innovative, reliable gene-based diagnostic solutions targeting women's cancers and infectious diseases worldwide.

Founded 1987 36 employees Post-IPO Equity Total: $103.50M Biotechnology, Manufacturing

General Information

Company Name Digene Corporation
Founded Year 1987
Founders / Decision Makers
Team member
Employees 36
Industries Biotechnology, Manufacturing
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Digene Corporation. To contact Digene Corporation, visit digene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Digene Corporation compare?

A PDF of Digene Corporation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Digene Corporation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Digene Corporation

Digene Corporation is a biotechnology and manufacturing company that focuses on developing, manufacturing, and marketing proprietary gene-based diagnostic tests for screening, monitoring, and diagnosing human diseases, particularly women’s cancers and infectious diseases worldwide. Established in 1987, the company's flagship product, The Digene HPV Test, is an FDA-approved diagnostic tool specifically designed to detect human papillomavirus (HPV), a significant cause of cervical cancer. The company received a notable $84.00M Post-IPO Equity investment on 17 November 2005. With its innovative and reliable solutions, Digene Corporation is making impactful strides in pushing the boundaries of gene-based diagnostics.

Business keywords: gene-based diagnostic solutions, women's cancers, infectious diseases, global healthcare, proprietary diagnostic tests, HPV testing, cervical cancer screening, FDA-approved, health technology, disease monitoring, diagnostic tools, oncology diagnostics, precision medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $84.00M -
17 Nov 2005
Post IPO Equity $19.50M -
17 Jan 2000

Digene Corporation Alternatives & Competitors

View All Alternatives
Digene Corporation vs
Aidian
Aidian Finland

Aidian develops, manufactures and markets diagnostic tests and test solutions.

Venture round
205 employees
Biotechnology, Health Care
Digene Corporation vs

Our Tests. Your Total Solution.

Post-IPO Debt
74 employees
Biotechnology, Health Care
Digene Corporation vs
Quidel
Quidel United States

Follow us now at linkedin.com/company/quidelortho/

IPO
502 employees
Biotechnology, Health Care

FAQ About Digene Corporation

Innovative, reliable gene-based diagnostic solutions targeting women's cancers and infectious diseases worldwide.
Digene Corporation was founded in 1987.
Digene Corporation operates in Biotechnology and Manufacturing. Its work centres on gene-based diagnostic solutions, women's cancers, infectious diseases and global healthcare.
Digene Corporation has approximately 36 employees.
Digene Corporation has completed 2 funding rounds, raising a total of $103.50M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Digene Corporation include Aidian, Response Biomedical Corp., Quidel, Nucleix Ltd., IMMY. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Digene Corporation and Aidian are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Digene Corporation, https://bouncewatch.com/company/digene-corporation, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout